Get started
Author

Prabhdeep K Grewal

Observed names: P Grewal, Prabhdeep Grewal
ORCID: 0000-0002-2452-3952
Observed ORCID: 0000-0002-2452-3952
OpenAlex ID: A5003211806
Twelve-month results from a randomized controlled trial comparing differential target multiplexed spinal cord stimulation and conventional spinal cord stimulation in subjects with chronic refractory axial low back pain not eligible for spine surgery
2024 · Thomas White, Rafael Justiz, et al. · North American Spine Society Journal (NASSJ) · 21
PDF
Recommendations and Guidance for Steroid Injection Therapy and COVID-19 Vaccine Administration from the American Society of Pain and Neuroscience (ASPN)
2021 · Krishnan Chakravarthy, Natalie Strand, et al. · Journal of Pain Research · 19
PDF
Low‐energy differential target multiplexed SCS derivative reduces pain and improves quality of life through 12 months in patients with chronic back and/or leg pain
2024 · Jeffery Peacock, David Provenzano, et al. · Pain Practice · 4
History of SCS and patient-focused innovations: a manufacturer’s perspective on the role of technology
2026 · Michael A Fishman, John A Hatheway, et al. · Pain Medicine · 1
Modeling Energy Demands of a DTM™ SCS Therapy Derivative on Rechargeable and Recharge-Free Systems
2023 · David Provenzano, Kasra Amirdelfan, et al. · Neuromodulation Technology at the Neural Interface · 1
ID:15988 Characterization of Different Energy Profiles of Differential Target Multiplexed™ Spinal Cord Stimulation
2022 · Michael Fishman, John Hathaway, et al. · Neuromodulation Technology at the Neural Interface · 1
ID# 1901153 DTM SCS rescues failed Conventional SCS in chronic back pain patients ineligible for spine surgery
2025 · Thomas White, Rafael Justiz, et al. · Neuromodulation Technology at the Neural Interface
ID# 1901067 DTM SCS for chronic back pain patients ineligible for spine surgery: US RCT functional outcomes
2025 · Thomas White, Rafael Justiz, et al. · Neuromodulation Technology at the Neural Interface
O112 Differential Target Multiplexed Spinal Cord Stimulation for Indicated Chronic Back Pain Patients Ineligible for Spine Surgery: Us Rct Outcomes
2025 · Thomas White, Rafael Justiz, et al. · Neuromodulation Technology at the Neural Interface
DTM™ Spinal Cord Stimulation for Indicated Chronic Back Pain Subjects Ineligible for Spine Surgery: 12-Month Outcomes from a U.S. RCT
2025 · Richard Bundschu, Thomas White, et al. · Interventional Pain Medicine
ID: 341936 Patient Activity Goals & Therapy Satisfaction with a Reduced-Energy DTM™-Derivative: 12-Month Outcomes from a Multi-Center-Study
2024 · Jeffrey Peacock, David Provenzano, et al. · Neuromodulation Technology at the Neural Interface
ID: 208527 Long-Term Clinical Outcomes of a Low-Energy Derivative Study of Differential Target Multiplexed Spinal Cord Stimulation
2023 · David Provenzano, Celeste Porritt, et al. · Neuromodulation Technology at the Neural Interface
ID: 212058 Modeling the Impact of a DTM(TM) Derivative on Rechargeable and Recharge-Free SCS Systems
2023 · David Provenzano, Maddie LaRue, et al. · Neuromodulation Technology at the Neural Interface
6-month Prospective Study Outcomes of a DTM™ SCS Therapy Derivative
2023 · Jeffrey Peacock, David Provenzano, et al. · Neuromodulation Technology at the Neural Interface
A Prospective Multi-Center Study of a Differential Target Multiplexed Stimulation Derivative in Therapy-Naive Patients: 3-Month Outcomes and Energy Use
2022 · Jeffrey Peacock, David Provenzano, et al. · Neuromodulation Technology at the Neural Interface
ID:16373 Prospective Multi-Center Study of a DTM™ SCS Derivative in Therapy-Naive Patients: Primary and 3-Month Outcomes
2022 · Jeff Peacock, David Provenzano, et al. · Neuromodulation Technology at the Neural Interface
B381 A modified energy DTM™ SCS therapy: 6-month outcomes of a prospective, multi-center study on patients with chronic back and leg pain
2022 · J Peacock, D Provenzano, et al. · Regional Anesthesia & Pain Medicine
PDF
Works count: 17
Citation count: 47
H-index: 3
I10-index: 2
Year
Topic
Type